BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. NEUROG3, glucose metabolic process, Inflammatory disorder, Intestine, Amniocentesis)
Bookmark Forward

QuickView for YDL147W;jsessionid=4B88CBCD4DA41E919C3EBB0D1CC53192;jsessionid=E2AC1F4BF6A3858B17D91DE1BC306600;jsessionid=B2A270200C948D5546B15730E776375A;jsessionid=ECDBAEEEDA94924F085478F777D3A2D0;jsessionid=A526AF8B96D59E81C2355B5ED014FE82;jsessionid=FC9FD7977210A84F177AE0BAE789C388;jsessionid=568FB56A9123A923DB5923B5E43F2A11;jsessionid=FED9372CE22881A9DDBAC6E8D341AA83 (gene)


Body Atlas

Most Correlated Tissues

  1. Dendritic (plasmacytoid) cell
  2. Thalamus lateral nuclei
  3. Cerebellar hemisphere
  4. Substantia nigra pars compacta
  5. Substantia nigra reticulata
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Perforation of tympanic membrane
  2. Septicemia due to Enterococcus
  3. Developmental mental disorder
  4. Mental retardation
  5. Infection by Schistosoma
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Roxarsone
  2. N-palmitoyl-S-(2,3-bis(palmitoyloxy)propyl)cysteinyl-seryl-lysyl-lysyl-lysyl-lysine
  3. Hexamethonium
  4. Khellin
  5. 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CDHR2
  2. EIF3A
  3. SPOP
  4. TLR2
  5. KRT1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Clinical characteristics and genetic analysis of a patient with STISS syndrome due to variant of PSM…
  2. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
  3. NMR 1H, 13C, 15N backbone and side chain resonance assignment of the N-terminal domain of yeast prot…
  4. PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway.
  5. PSMD12 promotes glioma progression by upregulating the expression of Nrf2.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for YDL147W;jsessionid=4B88CBCD4DA41E919C3EBB0D1CC53192;jsessionid=E2AC1F4BF6A3858B17D91DE1BC306600;jsessionid=B2A270200C948D5546B15730E776375A;jsessionid=ECDBAEEEDA94924F085478F777D3A2D0;jsessionid=A526AF8B96D59E81C2355B5ED014FE82;jsessionid=FC9FD7977210A84F177AE0BAE789C388;jsessionid=568FB56A9123A923DB5923B5E43F2A11;jsessionid=FED9372CE22881A9DDBAC6E8D341AA83
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.